Huiyu Pharmaceutical announced that Mr. Yang Bo, a shareholder who owns more than 5% but not the largest shareholder in the company, plans to reduce his shareholding of 345,000 shares through centralized bidding, which accounts for 0.081% of the total share capital of the company. The period of reduction is from June 26, 2024 to September 13, 2024.
汇宇制药：杨波先生拟减持345000股
Mr. Yang Bo of Huiyu Pharmaceutical intends to reduce his shareholding of 345,000 shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.